SMTL ID : 3ewj.1 (1 other biounit)

Crystal structure of catalytic domain of TACE with carboxylate inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.191, H.195, H.201 Ligands: INN.2 5 PLIP interactions: 3 interactions with chain A, 1 Ligand-Ligand interactions, 1 Ligand-Water interactions Metal complexes: A:H.191, A:H.195, A:H.201, INN.2, H2O.5

1 x INN: N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide(Non-covalent)

INN.2: 17 residues within 4Å: Chain A: M.131, G.132, T.133, L.134, G.135, N.175, Y.176, V.188, H.191, E.192, H.195, H.201, Y.222, P.223, I.224, A.225 Ligands: ZN.1 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.134, A:H.191, A:I.224, A:A.225 Hydrogen bonds: A:G.132, A:L.134, A:G.135, A:N.175, A:P.223, A:A.225

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Guo, Z. et al., Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors. Bioorg.Med.Chem.Lett. (2009)

Release Date

2008-11-18

Peptides

ADAM 17: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ADAM 17

Related Entries With Identical Sequence